Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 22,195 MLTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 22,195 | n/a |
| Jun 17, 2026 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 63,481 | n/a |
| Jul 7, 2025 | MoonLake Immunotherapeutics (MLTX) | Exercise/Conversion | 23,500 | n/a |
| Jun 12, 2025 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 45,000 | n/a |
| Jun 9, 2025 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 6,682 | n/a |
| Jun 21, 2024 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 24,311 | n/a |
| Jun 10, 2024 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Sale | 44,426 | $282.5K |
| Jun 7, 2024 | MoonLake Immunotherapeutics (MLTX) | Grant/Award | 7,688 | n/a |
| Dec 19, 2023 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 1,572 | n/a |
| Sep 19, 2023 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 2,098 | n/a |